This report highlights the long-term management of velopharyngeal insufficiency (VPI) and misarticulation in an 18-year-old male with unilateral cleft lip and palate. Despite primary and secondary surgeries, persistent VPI required a speech appliance and intensive therapy to address glottal stops and pharyngeal fricatives. While therapy eliminated these errors, residual VPI continued to impact speech intelligibility. Reassessment revealed that while some misarticulations persisted , the patient retained speech improvements from prior therapy , allowing for partial substitutions of target sounds . This case emphasizes the role of speech therapy in managing misarticulation despite unresolved VPI and highlights the need for ongoing multidisciplinary care.
Background/Objectives: Non-syndromic cleft lip with or without palate (NSCL/P) is a common, multifactorial congenital anomaly. As genetic associations can be population-specific, this study aimed to investigate single-nucleotide polymorphisms (SNPs) in the VAX1, MAFB, and WNT3 genes for association with NSCL/P in a Japanese cohort. Methods: A case–control study was conducted with 310 Japanese patients with NSCL/P and 308 ethnically matched healthy controls from Aichi Gakuin Dental Hospital. We genotyped SNPs rs7078160 (VAX1), rs13041247 (MAFB), and rs3809857 (WNT3) using TaqMan assays. Associations were assessed using chi-squared tests, with results stratified by sex and corrected for multiple comparisons using the Bonferroni method. Results: The VAX1 rs7078160 A allele was significantly associated with an increased risk for NSCL/P (OR = 1.67, p < 0.00001). The association was particularly strong in females (OR = 1.93, p < 0.00001) but not significant in males after correction. The MAFB rs13041247 variant showed a nominal protective association with the NSCLO subtype that was not significant after Bonferroni correction. No significant association was found for WNT3. A notable gene–gene interaction was observed, where carrying risk alleles for both VAX1 and MAFB significantly increased overall NSCL/P risk (OR = 2.65, p = 0.00008). Conclusions: VAX1 rs7078160 is a significant risk factor for NSCL/P in the Japanese population, with a pronounced female-specific effect. A synergistic interaction between VAX1 and MAFB elevates disease risk, whereas WNT3 was not implicated in this cohort. These findings underscore the population-specific genetic architecture of NSCL/P.
Chlorhexidine digluconate (CHX) is widely recognized for its antimicrobial properties and potential use as an irrigant in endodontic treatment. However, its specific role in the treatment of primary teeth remains uncertain. This review aimed to evaluate the effectiveness of CHX in cleaning the root canal system in pediatric endodontic treatment. A total of 46 studies were initially identified from three databases: PubMed (5), ScienceDirect (2), and Cochrane (0). Following selection based on PRISMA-ScR 2018 guidelines, seven studies met all inclusion criteria and were included in the qualitative analysis. The findings indicate that CHX 2% demonstrates good antibacterial efficacy but lacks the ability to dissolve inorganic tissue. Additionally, its safety and effectiveness in dissolving organic tissue in primary teeth have yet to be thoroughly investigated. The minimum irrigation volume when using CHX is 2 ml per root canal, which ensures optimal effectiveness in bacterial elimination and improves treatment outcomes. While CHX shows promise as an endodontic irrigation solution for primary teeth, further research is necessary to fully understand its potential benefits and limitations.